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Abstract
Clinical Vignette: A 73-year-old female with essential tremor (ET) underwent bilateral thalamic ventralis intermedius (Vim) deep brain stimulation (DBS)
surgery. The leads provided tremor benefit, but the location was suboptimal and contributed to stimulation-induced hemichorea.
Clinical Dilemma: Can patients with ET derive benefit when stimulating outside the Vim? What do we know about stimulation-induced hemichorea in the setting of ET?
Clinical Solution: Lead localization combined with advanced programming strategies can be employed to troubleshoot DBS in settings when benefits are
observed along with adverse effects.
Gap in Knowledge: Sparse information exists about DBS when applied to neuroanatomic regions outside the Vim for the management of ET. Subthalamic
nucleus DBS-induced chorea has been reported in multiple movement disorders, but not in ET.
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Clinical vignette
A 73-year-old female with a longstanding history of a disabling
essential tremor (ET) underwent planned bilateral thalamic ventralis
intermedius (Vim) deep brain stimulation (DBS) at an external facility
(MedtronicTM, 3387). At the University of Florida (UF), examination
was consistent with ET with no evidence of parkinsonism. Tremor
benefit immediately following surgery was adequate but mildly waned
over the ensuing 2 years with concurrent emergence of a new, bother-
some, and near-constant involuntary movement of the right upper
extremity. Examination identified the movement as stimulation-induced
hemichorea (Video 1).
A monopolar threshold review was performed for both leads
(Table 1). The review of the right DBS lead resulted in sensory
side effects at modest voltages when activating the most ventral
contacts, while the left DBS lead resulted in chorea of the right
upper extremity when activating the two deepest (most ventral)
contacts.
Post-operative lead localization and three-dimensional mapping
identified that the lead locations were both suboptimal. The right DBS
lead was placed deep and near the border of the thalamic ventralis
oralis posterior (Vop) and ventralis oralis anterior (Voa) while the left
DBS lead was placed in the anterolateral portion of the subthalamic
nucleus (STN) with the lead trajectory also tangent to the posterior
subthalamic area (PSA) (Figures 1 and 2).
Clinical dilemma
While the patient manifested a significant tremor benefit, neither of her
DBS leads was within the traditional target for ET – the thalamic Vim.
Furthermore, she developed a rare side effect of stimulation, stimulation-
induced hemichorea.
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This clinical scenario brings to light a few important questions. First,
why did the patient have tremor benefit (though suboptimal and
limited by hemichorea) with STN–PSA stimulation? Second, why did
the patient have significant tremor control with Voa/Vop stimulation?
Clinical solution
Suboptimal lead location, as noted in this case, has been reported
as the most common reason for DBS to fail to provide the expected
benefit. It is also a common reason for unexpected side effects.
Suboptimal lead location accounts for nearly half of the DBS
troubleshooting referrals to tertiary care centers.1,2 It is important to
have a quality assessment procedure in place to evaluate the location of
the lead (by direct visualization via post-operative imaging) and to
determine its effectiveness (by direct stimulation via a monopolar
threshold review and programming).
There are a growing number of commercial and proprietary plat-
forms capable of performing lead location and visualization. For
example, at the UF, we use a UF-built proprietary platform to measure
the post-operative lead location and we obtain a monopolar threshold
review on all patients implanted with DBS regardless of whether they
are implanted in or out of our institution. When combining imaging
and programming, the result may clarify the clinical dilemma.
When faced with tight thresholds within the most effective DBS
contacts (e.g. you cannot raise the voltage to the desired level),
narrowing the stimulation field, which is referred to as the volume of
tissue activation, may be a necessary next step. This change is accom-
plished by using a bipolar programming scheme or by alternating the
area being stimulated through the use of interleaving. The latter
strategy is sometimes able to provide the desired benefit while avoiding
side effects.3 In this case, prior to presentation at UF, monopolar
programming configurations (C+ 1–, C+ 2–, and C+ 3–) were tried
for the left-sided lead with no improvement in tremor. Higher settings
led to the development of tingling and pulling sensations. Variation in
pulse width (PW) using 60, 90, or 120 ms or variation in stimulation
frequency (Freq) using 135, 185, 190, 200, and 210 Hz did not result in
tremor benefit. An interleaving combination (C+, 2–, 2 V, PW590 ms,
Freq5125 Hz and C+, 3–, 4 V, PW5120 ms, Freq5125 Hz), despite
lack of benefit in either setting, was attempted unsuccessfully. A double
Video 1. Postural and Intention Tremor Examination. The video starts
by tremor examination in the deep brain stimulation (DBS) ON state followed
by an examination in the DBS OFF state (1 month apart). It is notable that
there is limited DBS control of tremor on the right side of the body with
significant tremor control on the left side of the body. The stimulation settings
for the left-sided lead are interleaving C+, 2–, 2 V, PW590 ms, Freq5125 Hz
and C+, 3–, 4 V, PW5120 ms, Freq5125 Hz. The stimulation settings for the
right-sided lead are C+, 2–, 2.9 V, PW590 ms, Freq5160 Hz.
Table 1. Monopolar Threshold Review




0 0.5 Tingling of the left face,
arm, and leg
1 1.0 Tingling of the left face
and leg
2 3.0 Tingling of the left hand
3 3.6 Tingling of the left face
and leg
Left lead
0 0.9 Chorea in the right arm
1 1.0 Chorea in the right arm
2 2.6 Subjective ‘‘dizziness’’
3 3.5 Tingling of the head
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bipolar configuration (1+, 2– 3–, 2.5 V, PW590 ms, Freq5185 Hz)
provided mild tremor control with delayed-onset hemichorea.
Decreasing the stimulation voltage to 2 V improved but did not
resolve the hemichorea and there was not a significant change in tremor.
At UF, a simple bipolar configuration of the left-sided lead (2+, 3–,
3.5 V, PW590 ms, Freq5180 Hz) provided acute, mild tremor benefit
Figure 1. Postoperative Lead Location Mapping. The dashed red line is the location of the DBS lead based on magnetic resonance imaging. The thalamus
(green), striatum (blue), globus pallidus external segment (green), globus pallidus internal segment (orange) and subthalamic nucleus (red) are outlined as shown.
The approximate location of the contacts is shown as white dots.
Figure 2. Important Anatomic Landmarks for Essential Tremor Deep Brain Stimulation. The left panel shows the unenhanced load location map as
noted in Figure 1. The right panel shows the location of important anatomic structures in relation to the deep brain stimulation (DBS) lead. Vim, yellow-filled
structure; Vop, orange structure; Voa, dark blue structure; Raprl, gray structure; ZI, light blue structure; red nucleus, purple structure; and STN, red structure.
The white solid line represents the right-sided DBS lead of the patient.
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without hemichorea, though the patient was hesitant to try this setting
at home and preferred instead to inactivate her left-sided DBS.
She was not interested in repeat surgery to revise the lead location.
The programming attempts were adequate according to published
recommended protocols.4 For the right-sided lead, a simple monopolar
configuration (C+, 2–, 2.9 V, PW590 ms, Freq5160 Hz) provided
significant improvement in tremor (postural and kinetic).
Two interesting observations can be derived from this case. First,
suppression of tremor was observed with activation in areas outside
of the thalamic Vim. Additionally, anterolateral STN DBS induced
hemichorea. We will discuss both observations.
Gap in knowledge
Effective targets for deep brain stimulation in essential tremor
While the thalamic Vim remains the gold standard and most con-
ventional target for DBS in ET, there is ongoing discussion regarding
the precise substructure or fiber tract responsible for tremor control.
Most experts agree that modulation of the cerebello-thalamo-cortical
network is important for providing tremor benefit.5,6 Within this area,
however, recent studies, including those utilizing tractography, have
shown that the dentato-rubral-thalamic tract may be important to
provide this benefit.7–9
A few published cases and studies have examined other targets
beyond the Vim for tremor and have observed adequate tremor control.
Stover et al.5 published a case where posterior STN DBS resulted
in control of both ET and Parkinson’s disease (PD), though, notably,
the patient had a pallidotomy and VIM DBS to address the tremor
in the other hand. Another study recruited eight patients with severe
proximal ET to undergo placement of DBS in the white matter
surrounding the STN, rather than in the STN itself.10 The stimulated
area in this study was thought to involve the PSA, a distinct area that is
posterior, superior, and medial to the STN that houses fiber bundles
from both the zona incerta (ZI) and prelemniscal radiations (Raprl).
This study’s result has been reproduced and it suggested that PSA DBS
might be more beneficial than Vim DBS for tremor control.11 Whether
this effect was due to stimulation of the ZI12,13 or due to the Raprl14
remained unclear.
For now, the Vim remains the target of choice for DBS in ET.
Newer technologies have utilized tractography. There has also been
advancement in post-operative lead imaging and this has led to a shift
toward steering the direction of electrical stimulation. These advances
have collectively led to more precision in ablative ET procedures.15
Tractography, for example, allows the clinician to see the cerebel-
lothalamic tract passing through the PSA, which could be useful for
management and placement of DBS.16
One important note in this case was that one of the leads was
suboptimally placed in the Voa/Vop region and that this lead pro-
vided adequate tremor control without the need for revision. Voa/Vop
is largely a pallidal receiving area whereas Vim is mostly a cerebellar
receiving area. This raises the question of whether the circuitry for
ET is circumscribed to cerebellar regions or whether the clinical
phenotype includes tremors with contributions from pallidal oscilla-
tors. This remains unknown. A recent paper by Oliverio et al.17
did however show tremor control in multiple sclerosis with an anterior
lead located in the Voa/Vop. There are also other papers in the
literature showing Voa/Vop may be viable for treatment of ET.18,19
Chorea induced by deep brain stimulation
A recent review by Baizabal-Carvallo and Jankovic20 outlined the
movement disorders that can be potentially induced by DBS. Among
these was chorea. There was one case that described choreic/ballistic
movements occurring during stimulation of the anteromedial STN
in a patient with obsessive–compulsive disorder.21 More often in the
literature chorea is included in the single term ‘‘dyskinesia’’ and was
observed almost exclusively in the context of STN DBS for PD.22,23
The association between STN and chorea is not limited to stimula-
tion. Alvarez et al.24 published the longitudinal follow-up of PD
patients who received unilateral subthalamotomy. Notably, 15% of the
patients (14 patients) developed post-operative hemichorea/hemiballism
and 57% (eight of the 14 patients) required a rescue pallidotomy to
treat this severe complication. In addition, chorea is a known compli-
cation of stroke in the subthalamic area.25
The overall mechanism by which STN stimulation or ablation
resulted in chorea, whether directly or indirectly, has not been well
understood and has also not been previously described in the setting
of ET. Moreover, the DBS lead causing chorea in this case is located
in a relatively more anterior position than is typical for STN DBS
in PD, indicating that different subregions of STN can induce this
complication.
Since in the future we may be using STN and peri-STN pathways
(such as the cerebellothalamic tract in the PSA) more frequently for ET
management, a more thorough evaluation of possible stimulation-
induced side effects, as observed in this case, will be required.
Expert commentary
This case is of great utility to both the novice and the advanced
DBS provider. It highlights the importance of standardized procedures
for assessing patients who are receiving suboptimal benefit and/or
adverse effects following DBS. Post-operative imaging and review
of the monopolar threshold were useful for uncovering the main
issues driving the outcome. Programming thresholds should always
be combined with imaging to ultimately arrive at a decision about
a suboptimal lead. This case draws attention to the continued need
to better understand the physiological underpinnings of DBS and it
also highlights the need to further characterize different DBS targets
for ET. The development of chorea with STN DBS for ET was
intriguing but not unexpected. Are there common specific substruc-
tures and circuitries within STN that underpin DBS-induced chorea in
ET and other movement disorders? In the future, tractography-based
surgical targeting may better refine lead placement and possibly reduce
adverse effects.26
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